comparemela.com

Latest Breaking News On - European breast cancer conference - Page 1 : comparemela.com

Supervised Exercise Improves Patient-Reported Outcomes for Metastatic Breast Cancer

Findings for fatigue, health-related quality of life, and pain. Findings for fatigue, health-related quality of life, and pain.

Utrecht
Netherlands
Milan
Lombardia
Italy
Anouk-hiensch
University-medical-center-utrecht
Healthday-news
European-breast-cancer-conference

Local Recurrence Rate Low With Radiation Boost in Breast Cancer Patients

For young patients, high boost dose yields slightly better local control, but increased incidence of fibrosis in boost area. For young patients, high boost dose yields slightly better local control, but increased incidence of fibrosis in boost area.

Milan
Lombardia
Italy
Amsterdam
Noord-holland
Netherlands
Sophie-bosma
Netherlands-cancer-institute
Healthday-news
European-breast-cancer-conference

Atezolizumab + Chemo After Surgery Does Not Improve Survival for Triple-Negative Breast Cancer

Among the patients taking atezolizumab, 12.8% had a recurrence or died vs 11.4% not taking atezolizumab.

Dallas
Texas
United-states
Milan
Lombardia
Italy
University-of-texas-southwestern-medical-center
Heather-mcarthur
Healthday-news
European-breast-cancer-conference
Texas-southwestern-medical-center

'Excellent' Outcomes After Complete Response in Lymph Node-Positive Breast Cancer

Similar survival regardless of adjuvant therapy, even with omission of RT and axillary dissection

Netherlands
New-york
United-states
Milan
Lombardia
Italy
Maastricht
Limburg
Dutch
Nancy-chan
Charles-bankhead
Langone-health-perlmutter-cancer-center

Drug breakthrough could benefit those with common breast cancer

Treating patients who have a common form of breast cancer with immunotherapy, as well as chemotherapy, before and after surgery could be effective.

United-kingdom
Belgium
Brussels
Bruxelles-capitale
Barcelona
Comunidad-autonoma-de-cataluna
Spain
Milan
Lombardia
Italy
Institut-jules-bordet
Javier-cortes

vimarsana © 2020. All Rights Reserved.